Application | Comment | Organism |
---|---|---|
drug development | synthesis of a series of naphthyl-based compounds, which are potential inhibitors of vascular endothelial growth factor receptors | Mus musculus |
drug development | synthesis of a series of naphthyl-based compounds, which are potential inhibitors of vascular endothelial growth factor receptors | Homo sapiens |
drug development | synthesis of a series of naphthyl-based compounds, which are potential inhibitors of vascular endothelial growth factor receptors | Rattus norvegicus |
Crystallization (Comment) | Organism |
---|---|
cocrystallization of KDR with inhibitor N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide. The inhibitor binds to the ATP binding site of KDR and forces the protein to adopt a DFG-out conformation, enabling the p-chlorophenyl ring to penetrate into the extended hydrophobic pocket. A highly conserved hydrogen-bond interaction between the backbone amide-NH of Cys919 and the nitrogen of the quinoline ring anchors the inhibitor to the hinge region of the binding pocket and orients the naphthyl ring into the hydrophobic pocket. The carbonyl and NH groups of the amide form critical hydrogen bonds with the backbone NH of Asp1046 and the side chain of Glu885, respectively | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
4-(5-((4-chlorophenyl)carbamoyl)naphthalen-2-yloxy)-7-methoxyquinoline-6-carboxamide | - |
Homo sapiens | |
4-(5-((4-chlorophenyl)carbamoyl)naphthalen-2-yloxy)-N-methylpicolinamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(2-fluorophenyl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-fluorophenyl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-methylisoxazol-5-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(4-fluorophenyl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(5-methylisoxazol-3-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(isoxazol-3-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-2-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-3-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-4-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-(thiazol-2-yl)-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-isopropyl-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-p-tolyl-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-phenyl-1-naphthamide | - |
Homo sapiens | |
6-(6,7-dimethoxyquinolin-4-yloxy)-N-propyl-1-naphthamide | - |
Homo sapiens | |
6-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-N-(4-chlorophenyl)-1-naphthamide | - |
Homo sapiens | |
N-(2,4-dichlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(3,5-dichlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(3-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chloro-3-(trifluoromethyl)phenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-3-(6,7-dimethoxyquinolin-4-yloxy)isoquinoline-8-carboxamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-((6,7-dimethoxyquinolin-4-yl)(methyl)amino)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(2-(methylamino)pyridin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(2-(methylamino)pyrimidin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(3-fluoro-6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(6,7-dimethoxyquinazolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-ylamino)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | has significant antitumor efficacy against established HT29 human colon adenocarcinoma xenografts implanted in athymic mice | Homo sapiens | |
N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | dose dependent inhibition of Flk-1 phosphorylation | Mus musculus | |
N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | shows in vivo inhibition of corneal angiogenesis | Rattus norvegicus | |
N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-5-fluoro-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(6-(methylamino)pyrimidin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(7-methoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(pyridin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(pyrimidin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-6-(quinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(4-chlorophenyl)-7-(6,7-dimethoxyquinolin-4-yloxy)quinoline-4-carboxamide | - |
Homo sapiens | |
N-(4-tert-butylphenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(5-tert-butylisoxazol-3-yl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-(cyclopropylmethyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-cyclobutyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-cyclopentyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens | |
N-cyclopropyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | - |
Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P35968 | - |
- |
Mus musculus | P35918 | Balb/c female mice | - |
Rattus norvegicus | O08775 | female Sprague-Dawley rats | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
cornea | - |
Rattus norvegicus | - |
HT-29 cell | - |
Homo sapiens | - |
HUVEC cell | - |
Homo sapiens | - |
lung | - |
Mus musculus | - |
Synonyms | Comment | Organism |
---|---|---|
Flk-1 | - |
Mus musculus |
KDR | - |
Mus musculus |
KDR | - |
Homo sapiens |
KDR | - |
Rattus norvegicus |
vascular endothelial growth factor receptor | - |
Mus musculus |
vascular endothelial growth factor receptor | - |
Homo sapiens |
vascular endothelial growth factor receptor | - |
Rattus norvegicus |
VEGF receptor | - |
Mus musculus |
VEGF receptor | - |
Homo sapiens |
VEGF receptor | - |
Rattus norvegicus |
VEGFR-2 | - |
Mus musculus |
VEGFR-2 | - |
Homo sapiens |
VEGFR-2 | - |
Rattus norvegicus |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.0000002 | - |
KDR enzyme | Homo sapiens | 4-(5-((4-chlorophenyl)carbamoyl)naphthalen-2-yloxy)-7-methoxyquinoline-6-carboxamide | |
0.0000002 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-phenyl-1-naphthamide | |
0.0000002 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(isoxazol-3-yl)-1-naphthamide | |
0.0000003 | - |
KDR enzyme | Homo sapiens | N-(3-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000003 | - |
KDR enzyme | Homo sapiens | N-(3,5-dichlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000003 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(thiazol-2-yl)-1-naphthamide | |
0.0000003 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-5-fluoro-1-naphthamide | |
0.0000004 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(isoxazol-3-yl)-1-naphthamide | |
0.0000005 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000005 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-p-tolyl-1-naphthamide | |
0.0000005 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide | |
0.0000005 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1-naphthamide | |
0.0000006 | - |
KDR enzyme | Homo sapiens | N-cyclopropyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000006 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-fluorophenyl)-1-naphthamide | |
0.0000006 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(5-methylisoxazol-3-yl)-1-naphthamide | |
0.0000007 | - |
KDR enzyme | Homo sapiens | N-(4-tert-butylphenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000008 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-2-yl)-1-naphthamide | |
0.0000008 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-3-yl)-1-naphthamide | |
0.0000008 | - |
KDR enzyme | Homo sapiens | N-(5-tert-butylisoxazol-3-yl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000008 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-phenyl-1-naphthamide | |
0.000001 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(7-methoxyquinolin-4-yloxy)-1-naphthamide | |
0.000001 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(4-fluorophenyl)-1-naphthamide | |
0.000001 | - |
KDR enzyme | Homo sapiens | N-(4-chloro-3-(trifluoromethyl)phenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000001 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-methylisoxazol-5-yl)-1-naphthamide | |
0.000001 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-cyclopropyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.0000013 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-propyl-1-naphthamide | |
0.000002 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinazolin-4-yloxy)-1-naphthamide | |
0.000002 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(2-fluorophenyl)-1-naphthamide | |
0.000002 | - |
KDR enzyme | Homo sapiens | N-(2,4-dichlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000002 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-4-yl)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinazolin-4-yloxy)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(4-fluorophenyl)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-p-tolyl-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-2-yl)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-3-yl)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(pyridin-4-yl)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(thiazol-2-yl)-1-naphthamide | |
0.000002 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-5-fluoro-1-naphthamide | |
0.000003 | - |
KDR enzyme | Homo sapiens | N-cyclobutyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000003 | - |
KDR enzyme | Homo sapiens | 4-(5-((4-chlorophenyl)carbamoyl)naphthalen-2-yloxy)-N-methylpicolinamide | |
0.000003 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 4-(5-((4-chlorophenyl)carbamoyl)naphthalen-2-yloxy)-7-methoxyquinoline-6-carboxamide | |
0.000003 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-fluorophenyl)-1-naphthamide | |
0.000004 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(quinolin-4-yloxy)-1-naphthamide | |
0.000004 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-isopropyl-1-naphthamide | |
0.000005 | - |
KDR enzyme | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-isopropyl-1-naphthamide | |
0.0000051 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(3-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000006 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(5-methylisoxazol-3-yl)-1-naphthamide | |
0.000007 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(2-(methylamino)pyridin-4-yloxy)-1-naphthamide | |
0.000007 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-cyclobutyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000007 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-cyclopentyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000007 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-propyl-1-naphthamide | |
0.000007 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(2-fluorophenyl)-1-naphthamide | |
0.000007 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-methylisoxazol-5-yl)-1-naphthamide | |
0.000008 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-ylamino)-1-naphthamide | |
0.000008 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000008 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(7-methoxyquinolin-4-yloxy)-1-naphthamide | |
0.000009 | - |
KDR enzyme | Homo sapiens | N-cyclopentyl-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.00001 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-7-(6,7-dimethoxyquinolin-4-yloxy)quinoline-4-carboxamide | |
0.000014 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(2,4-dichlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000014 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(6,7-dimethoxyquinolin-4-ylamino)-1-naphthamide | |
0.000015 | - |
KDR enzyme | Homo sapiens | N-(cyclopropylmethyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000016 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1-naphthamide | |
0.000018 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(pyridin-4-yloxy)-1-naphthamide | |
0.00002 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(6-(methylamino)pyrimidin-4-yloxy)-1-naphthamide | |
0.00002 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(3-fluoro-6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000022 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-7-(6,7-dimethoxyquinolin-4-yloxy)quinoline-4-carboxamide | |
0.000023 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-3-(6,7-dimethoxyquinolin-4-yloxy)isoquinoline-8-carboxamide | |
0.000028 | - |
KDR enzyme | Homo sapiens | 6-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-N-(4-chlorophenyl)-1-naphthamide | |
0.000028 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(3,5-dichlorophenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000034 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(quinolin-4-yloxy)-1-naphthamide | |
0.000034 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(6,7-dimethoxyquinolin-4-yloxy)-N-(3-(trifluoromethyl)phenyl)-1-naphthamide | |
0.000037 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 6-(7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)-N-(4-chlorophenyl)-1-naphthamide | |
0.000046 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(2-(methylamino)pyrimidin-4-yloxy)-1-naphthamide | |
0.000063 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-tert-butylphenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000068 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(5-tert-butylisoxazol-3-yl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000069 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(3-fluoro-6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.00007 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(cyclopropylmethyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000106 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(6-(methylamino)pyrimidin-4-yloxy)-1-naphthamide | |
0.00014 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(2-(methylamino)pyridin-4-yloxy)-1-naphthamide | |
0.000175 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-3-(6,7-dimethoxyquinolin-4-yloxy)isoquinoline-8-carboxamide | |
0.00021 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | 4-(5-((4-chlorophenyl)carbamoyl)naphthalen-2-yloxy)-N-methylpicolinamide | |
0.00022 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(pyridin-4-yloxy)-1-naphthamide | |
0.000247 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chloro-3-(trifluoromethyl)phenyl)-6-(6,7-dimethoxyquinolin-4-yloxy)-1-naphthamide | |
0.000296 | - |
VEGF driven proliferation of HUVEC cell | Homo sapiens | N-(4-chlorophenyl)-6-(2-(methylamino)pyrimidin-4-yloxy)-1-naphthamide | |
0.00031 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-(pyrimidin-4-yloxy)-1-naphthamide | |
0.0014 | - |
KDR enzyme | Homo sapiens | N-(4-chlorophenyl)-6-((6,7-dimethoxyquinolin-4-yl)(methyl)amino)-1-naphthamide |